Sandra Levy
ARTICLES BY THIS AUTHOR
- 2/4/2020
Fresenius Kabi introduces Glucagon Emergency Kit
Fresenius Kabi's glucagon emergency kit provides a treatment for severe hypoglycemia in pediatric and adult patients with diabetes. - 2/3/2020
NACDS' Anderson addresses coronavirus and pharmacists' readiness in op-ed
Pharmacists are committed to responding to public health emergencies such as the coronavirus, and patients' needs every day, NACDS' Steve Anderson writes in an op-ed on Medium. - 2/3/2020
Towa closes acquisition of Esteve's generics division
Breckenridge is among the companies included in the acquisition. - 2/3/2020
Augia Pharma gets FDA nod for generic Rheumatrex
Methotrexate tablets have a market value of roughly $98 million for the 12 months ended December 2019, according to IQVIA. - 2/3/2020
McKesson sees revenue gains in Q3
McKesson's pharmaceutical and specialty solutions segment saw Q3 2020 revenue up 6% over Q3 2019, totaling $46.9 billion. - 2/2/2020
CVS Health slims down its board
CVS Health’s board will transition from 16 to 13 directors, with two longtime directors retiring and the former CEO of Aetna departing after the company's annual meeting. - 2/2/2020
Allergan launches Ubrelvy
Allergan is offering Ubrelvy for the acute treatment of migraine with or without aura in adults. - 2/2/2020
Seqirus gets FDA nod for Audenz
The FDA has approved the first adjuvanted, cell-based Pandemic Influenza A (H5N1) vaccine. - 2/2/2020
Global sales of branded generics are expected to grow by 8%
Antihypertensives are expected to be the best-selling global branded generics category. - 1/30/2020
FDA clear 2 generics from Alembic
Clobetasol propionate cream and azithromycin tablets had a market value of $57 million, and $129 million respectively.
